Sapporo / Bradford / Tokyo / La Jolla / Heidelberg / Toulouse / St. Louis / /
Company
CD40 Ab / IgG / agonistic Ab / Millipore / anti-TNFR1 Ab / Fujikura / Ambion Inc. / BD Biosciences / Amersham Biosciences / Macmillan Publishers Limited / /
Country
Germany / France / Japan / United States / /
Currency
pence / / /
Facility
Hokkaido University / TNFR1 complex / Burnham Medical Research Institute / TNFR1-containing Complex / hCD40-hDR6 complex / /
IndustryTerm
Network communications / chemical antagonists / immune signaling networks / cytotoxic chemical reagents / chemical cytotoxic drug / /
MedicalCondition
DF / human fibrosarcoma cells / several tumor / experimental immune-resistant tumor / Tumor necrosis factor-a / tumor / cancer / tumors / Disease / tumor necrosis / tumor necrosis factor / human cervical cancer / Infectious Diseases / /
MedicalTreatment
antibiotics / /
Organization
National Institution of Health / Hokkaido University Research Center for Zoonosis Control / Institute for Genetic Medicine / Hokkaido University Research Center / Functional association / 4Sanford-Burnham Medical Research Institute / Department of Bioresources / Hokkaido University / Japan Health Sciences Foundation / Institut Curie Section Recherche / / /
CLIPR-59 regulates TNF-α-induced apoptosis by controlling ubiquitination of RIP1